Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality.

Gustafsson D, Unwin R.

BMC Nephrol. 2013 Jul 29;14:164. doi: 10.1186/1471-2369-14-164. Review.

2.

Independent and conjoint associations of gout and hyperuricaemia with total and cardiovascular mortality.

Stack AG, Hanley A, Casserly LF, Cronin CJ, Abdalla AA, Kiernan TJ, Murthy BV, Hegarty A, Hannigan A, Nguyen HT.

QJM. 2013 Jul;106(7):647-58. doi: 10.1093/qjmed/hct083. Epub 2013 Apr 5.

PMID:
23564632
3.

Gout: an independent risk factor for all-cause and cardiovascular mortality.

Kuo CF, See LC, Luo SF, Ko YS, Lin YS, Hwang JS, Lin CM, Chen HW, Yu KH.

Rheumatology (Oxford). 2010 Jan;49(1):141-6. doi: 10.1093/rheumatology/kep364. Epub 2009 Nov 20.

PMID:
19933595
4.

Hyperuricemia and associated diseases.

Becker MA, Jolly M.

Rheum Dis Clin North Am. 2006 May;32(2):275-93, v-vi. Review.

PMID:
16716880
5.

The role of uric acid in the pathogenesis of human cardiovascular disease.

Kanbay M, Segal M, Afsar B, Kang DH, Rodriguez-Iturbe B, Johnson RJ.

Heart. 2013 Jun;99(11):759-66. doi: 10.1136/heartjnl-2012-302535. Epub 2013 Jan 23. Review.

PMID:
23343689
6.

Joint association of hyperuricemia and reduced GFR on cardiovascular morbidity: a historical cohort study based on laboratory and claims data from a national insurance provider.

Neri L, Rocca Rey LA, Lentine KL, Hinyard LJ, Pinsky B, Xiao H, Dukes J, Schnitzler MA.

Am J Kidney Dis. 2011 Sep;58(3):398-408. doi: 10.1053/j.ajkd.2011.04.025. Epub 2011 Jul 23.

PMID:
21783292
7.

[Hyperuricemia - more than gout : Impact on cardiovascular risk and renal insufficiency].

Sellin L, Kielstein JT, de Groot K.

Z Rheumatol. 2015 May;74(4):322-8. doi: 10.1007/s00393-014-1481-1. Review. German.

PMID:
25962453
8.

Serum uric acid and the risk of cardiovascular and renal disease.

Borghi C, Rosei EA, Bardin T, Dawson J, Dominiczak A, Kielstein JT, Manolis AJ, Perez-Ruiz F, Mancia G.

J Hypertens. 2015 Sep;33(9):1729-41; discussion 1741. doi: 10.1097/HJH.0000000000000701. Review.

PMID:
26136207
9.

[Studies on association between nonalcoholic fatty liver disease and hyperuricemia: current status and future prospects].

Li Y.

Zhonghua Gan Zang Bing Za Zhi. 2016 Feb;24(2):89-91. doi: 10.3760/cma.j.issn.1007-3418.2016.02.003. Review. Chinese.

PMID:
26983473
10.

Uric acid and diabetes: Is there a link?

Katsiki N, Papanas N, Fonseca VA, Maltezos E, Mikhailidis DP.

Curr Pharm Des. 2013;19(27):4930-7. Review.

PMID:
23278493
11.

Cardiovascular and renal effects of hyperuricaemia and gout.

Viazzi F, Leoncini G, Pontremoli R.

Reumatismo. 2012 Jan 19;63(4):253-62. doi: 10.4081/reumatismo.2011.253. Review.

PMID:
22303532
12.

Advanced kidney failure and hyperuricemia.

Murea M.

Adv Chronic Kidney Dis. 2012 Nov;19(6):419-24. doi: 10.1053/j.ackd.2012.07.008. Review.

PMID:
23089278
13.

Is there anything good in uric acid?

Alvarez-Lario B, Macarrón-Vicente J.

QJM. 2011 Dec;104(12):1015-24. doi: 10.1093/qjmed/hcr159. Epub 2011 Sep 9. Review.

PMID:
21908382
14.

Survival impact of serum uric acid levels in children and adolescents.

Hsia SH, Chou IJ, Kuo CF, See LC, Huang JL, Yu KH, Luo SF, Wu CT, Lin KL, Wang HS.

Rheumatol Int. 2013 Nov;33(11):2797-802. doi: 10.1007/s00296-013-2808-y. Epub 2013 Jul 2.

PMID:
23817870
15.

[Hyperuricemia and the metabolic syndrome].

Mitu F, Drăgan MV.

Rev Med Chir Soc Med Nat Iasi. 2009 Oct-Dec;113(4):1001-5. Romanian.

PMID:
20191866
16.

Associations of serum uric acid with cardiovascular events and mortality in moderate chronic kidney disease.

Navaneethan SD, Beddhu S.

Nephrol Dial Transplant. 2009 Apr;24(4):1260-6. doi: 10.1093/ndt/gfn621. Epub 2008 Nov 25.

17.

Uric acid as a potential mediator of cardiovascular morbidity in obstructive sleep apnea syndrome.

Kanbay A, Inonu H, Solak Y, Erden A, Uslu E, Yuksel SA, Ozturk MA, McFann K, Johnson RJ, Kanbay M.

Eur J Intern Med. 2014 Jun;25(5):471-6. doi: 10.1016/j.ejim.2014.04.005. Epub 2014 May 3.

PMID:
24793835
18.

The effects of hyperuricaemia on flow-mediated and nitroglycerin-mediated dilatation in high-risk patients.

Wong CK, Chen Y, Ho LM, Zhen Z, Siu CW, Tse HF, Yiu KH.

Nutr Metab Cardiovasc Dis. 2014 Sep;24(9):1012-9. doi: 10.1016/j.numecd.2014.02.006. Epub 2014 Mar 1.

PMID:
24680223
19.

Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout.

Perez-Ruiz F, Martínez-Indart L, Carmona L, Herrero-Beites AM, Pijoan JI, Krishnan E.

Ann Rheum Dis. 2014 Jan;73(1):177-82. doi: 10.1136/annrheumdis-2012-202421. Epub 2013 Jan 12.

PMID:
23313809
20.

Association of hyperuricemia with renal outcomes, cardiovascular disease, and mortality.

Liu WC, Hung CC, Chen SC, Yeh SM, Lin MY, Chiu YW, Kuo MC, Chang JM, Hwang SJ, Chen HC.

Clin J Am Soc Nephrol. 2012 Apr;7(4):541-8. doi: 10.2215/CJN.09420911. Epub 2012 Feb 2.

Supplemental Content

Support Center